Asthma Clinical Trials in Phoenix

Showing 41-60 of 348 trials

Preventing Asthma in High Risk Kids

NCT02570984

This trial is a randomized, double-blind, placebo controlled trial designed to test whether two years treatment of preschool children aged 2-3 years of age at high risk for asthma with omalizumab (anti-IgE) for two years will prevent the progression to childhood asthma, as reflected by a reduction in the prevalence of active asthma in the Final 12 months during 2 year observation period off study drug.

Asthma

Boston Children's Hospital200 participantsStarted Nov 2018

Phoenix, Arizona, United States • San Diego, California, United States • Aurora, Colorado, United States +10 more locations

COMPLETEDPhase 418 miles

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States

NCT05329194

To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied populations in the United States.

Asthma

AstraZeneca287 participantsStarted Apr 2022

Mobile, Alabama, United States • Gilbert, Arizona, United States • Long Beach, California, United States +34 more locations

Preventing Asthma in High Risk Kids

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States

Asthma Trials in Other Cities

Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

FebriDx® Pediatric Validation Study

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Longitudinal Study of Mitochondrial Hepatopathies

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

A Study of Inhaled AZD8630 in Adolescents With Asthma

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis

Tube Size Randomized Trial During Emergency Tracheal Intubation

Individualizing Treatment for Asthma in Primary Care (Full Study)

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Other Conditions in Phoenix